Medicare proposal may impact Research payments

From the Centers for Medicare & Medicaid Services (CMS): Applicable manufacturers are required to report numerous types of payments to physicians and teaching hospitals.  These are outlined in the statute and include categories, such as consulting fees, food and beverages, and research payments.   The proposed rule provides special consideration to research payments since collaboration between physicians and teaching hospitals, and manufacturers is essential to the development of new products.  Research payments often include payment for all research activities, including patient tests and supplies, and the administration of the study, so the proposed rule outlines procedures to ensure that the nature of these relationships is understood, but there is also sufficient information on the extent of the research relationship.  In addition to including information on the nature of these relationships, the statute also protects applicable manufacturer’s competitive interests, by allowing CMS to delay publication of certain research payments until the earlier of FDA approval of the product that is the subject of the research or four years after the payment date.  CMS is proposing to require manufacturers to report these payments must be reported in the year they were made, but to delay publication until the earlier of FDA approval or four years has passed.  

Read the proposed rule here: https://www.cms.gov/apps/media/press/factsheet.asp?Counter=4221&intNumPerPage=10&checkDate=&checkKey=&srchType=1&numDays=3500&srchOpt=0&srchData=&keywordType=All&chkNewsType=6&intPage=&showAll=&pYear=&year=&desc=&cboOrder=date